Aduro Biotech, Inc. ADRO

Full chart Compare
Set alert

Price alert · ADRO

All alert types
— —

Day range unavailable

52-week range unavailable

Market cap
236.61M
Forward P/E
-4.74
Analysts
Buy
Price target
18.75
Earnings date
Aug 3, 2020

 

No chart data for this range yet.

Key statistics

Price / sales
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
0
Total cash
0
Total debt
0
Return on equity
0.00%
50-day average
14.60
200-day average
3.08

Earnings

ADRO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 3, 2020Jun 1, 2020-0.19———
May 4, 2020Mar 1, 2020-0.11———
Mar 9, 2020Dec 1, 2019-0.21———
Nov 7, 2019Sep 1, 2019-0.23———
Aug 1, 2019Jun 1, 2019-0.16———
May 7, 2019Mar 1, 2019-0.17———

News

Your note

Sign in to keep a note on ADRO — it syncs with the Stock Master app.

Insider holders

ADRO insider holders
InsiderRelationLatest transactionDateShares held
FERBER CELESTE SGeneral CounselSaleSep 14, 202038,687
GREENMAN WILLIAM MARINERDirectorConversion of Exercise of derivative securityMar 17, 202019,835
HAGHIGHAT ROSS RDirectorStock Award(Grant)May 31, 2020437,058
ISAACS STEPHEN TChief Executive OfficerSaleSep 14, 2020288,098
KACHIOFF WILLIAM GChief Financial OfficerStock Award(Grant)May 31, 202010,000
LEW JENNIFERChief Financial OfficerSaleApr 30, 2019135,155

Institution ownership

ADRO institution ownership
Holder% heldSharesValueReported
Vivo Capital, LLC6.31%5,118,56059.12MJun 29, 2020
Renaissance Technologies, LLC5.73%4,644,31053.64MJun 29, 2020
Blackrock Inc.5.54%4,488,98451.85MJun 29, 2020
Baillie Gifford and Company5.28%4,282,72049.47MJun 29, 2020
Ikarian Capital, LLC4.16%3,369,97638.92MJun 29, 2020
Vanguard Group, Inc. (The)3.16%2,561,81029.59MJun 29, 2020